2021
DOI: 10.1038/s41436-021-01246-2
|View full text |Cite
|
Sign up to set email alerts
|

Delineating the molecular and phenotypic spectrum of the SETD1B-related syndrome

Abstract: Purpose Pathogenic variants in SETD1B have been associated with a syndromic neurodevelopmental disorder including intellectual disability, language delay, and seizures. To date, clinical features have been described for 11 patients with (likely) pathogenic SETD1B sequence variants. This study aims to further delineate the spectrum of the SETD1B-related syndrome based on characterizing an expanded patient cohort. Methods We perform an in-depth clinical char… Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

2
17
0
1

Year Published

2021
2021
2024
2024

Publication Types

Select...
8

Relationship

3
5

Authors

Journals

citations
Cited by 23 publications
(20 citation statements)
references
References 43 publications
(77 reference statements)
2
17
0
1
Order By: Relevance
“…Similarly, published cases often exhibited drug-resistant seizures, but sultiame has not been reported thus far. 8,9 As opposed to previous publications, we have long-term clinical data available until adulthood. Although our patient exhibited severe language delay since childhood, significant improvements were noted later on.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…Similarly, published cases often exhibited drug-resistant seizures, but sultiame has not been reported thus far. 8,9 As opposed to previous publications, we have long-term clinical data available until adulthood. Although our patient exhibited severe language delay since childhood, significant improvements were noted later on.…”
Section: Discussionmentioning
confidence: 99%
“…Similarly, published cases often exhibited drug-resistant seizures, but sultiame has not been reported thus far. 8,9…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…has now led to the conclusions that most of the phenotypes associated with these microdeletion syndromes are caused by alterations of the genes CNOT2 (Alesi et al, 2017) and SETD1B (Weerts et al, 2021), respectively. It is expected that further progress in genetics, cell biology and personalized medicine will advance options to influence the phenotypes by gene-specific or pathway driven therapeutics.…”
Section: Discussionmentioning
confidence: 99%
“…Other examples include a variant in a silencer of NOTCH1, which was shown to contribute to Tetralogy of Fallot (a congenital heart disease) [57] and translocations of the NCREs of PAX6 that lead to aniridia [56]. Multiple disease examples show that the human brain seems particularly sensitive to gene expression disbalance [4,43,58], and many neurodevelopmental disorders are linked to chromatin modifiers [5,[59][60][61][62][63][64] and architectural proteins with roles in establishing chromatin conformation, such as CTCF, YY1 and STAG1 [1,3,4,65,66]. In this section, we will focus on a number of recent examples that illustrate the wide range of alterations of gene regulatory processes that can cause brain-related disorders, and the novel approaches to identify them.…”
Section: Non-coding Variants In the Context Of Genetic Brain Diseasementioning
confidence: 99%